Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone for THC-induced psychosis and cognitive impairment
NCT02576912Phase 1Completed
- Sponsor
- Yale University
- Start
- Feb 2015
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pregnenolone in schizophrenia, sponsored by Yale University. Started Feb 2015; status: completed.
02
Drugs
pregnenolone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02576912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02576912.